Cargando…
Observed reduction in the diagnosis of acute lymphoblastic leukaemia in children during the COVID‐19 pandemic
Autores principales: | Jarvis, Kirsten Brunsvig, Lind, Andreas, LeBlanc, Marissa, Ruud, Ellen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537500/ https://www.ncbi.nlm.nih.gov/pubmed/32959407 http://dx.doi.org/10.1111/apa.15576 |
Ejemplares similares
-
Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia
por: Infante-Rivard, C, et al.
Publicado: (2000) -
Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA
por: Groves, F D, et al.
Publicado: (1999) -
Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia
por: Zhu, Y-M, et al.
Publicado: (1999) -
CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia
(ALL)
por: Vorwerk, P, et al.
Publicado: (2000) -
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)
por: Donadieu, J, et al.
Publicado: (2000)